Suchergebnisse - "Zaliani, Andrea"

PubPharm (7)

1

Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex

enthalten in: Virus research | 2024

von Kuzikov, M. | Reinshagen, J. | Wycisk, K. | +11

2

Drug repurposing for the treatment of COVID-19 : Targeting nafamostat to the lungs by a liposomal delivery system

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2023

von Reus, P. | Guthmann, H. | Uhlig, N. | +15

3

Easy access to α-ketoamides as SARS-CoV-2 and MERS Mpro inhibitors via the PADAM oxidation route

enthalten in: European journal of medicinal chemistry | 2022

von Pelliccia, S. | Cerchia, C. | Esposito, F. | +10

4

Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development

enthalten in: Angewandte Chemie (International ed. in English) | 2022

von Berg, H. | Wirtz Martin, M. | Altincekic, N. | +80

5

High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2022

von Kuzikov, M. | Woens, J. | Zaliani, A. | +5

6

The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2

enthalten in: Stem cell reports | 2022

von Krasemann, S. | Haferkamp, U. | Pfefferle, S. | +38

CommentIn: Stem Cell Reports. 2022 May 10;17(5):1012-1013. - PMID 35545022

7

Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L

enthalten in: International journal of molecular sciences | 2021

von Costanzi, E. | Kuzikov, M. | Esposito, F. | +8

1
[1]